Clinical trial
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma
NCT02273856 is registered in ClinicalTrials.gov with Astellas Pharma International B.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma
- Lead sponsor
- Astellas Pharma International B.V.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2015
- Completion date
- August 31, 2015
- Enrollment
- 25 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lymphocytic leukaemia (cll), indolent non hodgkin's lymphoma (inhl)